AIDA

AIDA - An Artificially Intelligent Diagnostic Assistant for gastric inflammation

AIDA is a multidisciplinary AI-powered assistive tool that helps doctors diagnose precancerous lesions, offers personalized therapeutic strategies for medical treatment, and provides personalized recommendations for monitoring patients' health status, promoting gastric cancer prevention.

Most cases of stomach cancer are detected at a late stage - when the patient's survival is predicted only for a year. The potential risk of developing stomach cancer can be detected at an early stage of its development, which is usually indicated by a chronic infection with the bacterium H. pylori residing in the stomach. This can greatly improve the patient's chances.

The AIDA project supports doctors and researchers by providing accurate and automated data analyses. It combines data from various sources to create a vast virtual data set to obtain a "risk score" for stomach cancer and discover the mechanisms of its development.

Project ID No.: 101095359 LU reģ. Nr. ZD2022/21386

Leading partner: FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVA (INCLIVA) (Spain)

Project partners: LATVIJAS UNIVERSITATE (LU); INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO (I3S); SERVICIO MADRILENO DE SALUD (SERMAS); FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA (FCRB-CERCA); CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES (CHU-Nantes); LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS (LSMU); INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL, EPE (IPO Porto); ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (Erasmus MC); STRATEJAI (Stratejai); DIGESTIVE CANCERS EUROPE DICE (DiCE); IMPERIAL COLLEGE LONDON.

Project implementation: 01.01.2023. – 31.12.2026.

Total funding of UL: 755250,00 EUR

More information on project website